Browse the evidence

Five days of bed rest does not significantly alter skeletal muscle mitochondrial protein content, enzyme activity, or dynamics (fission/fusion/biogenesis/mitophagy markers) in healthy older adults.

For older adults facing short hospital stays (around 5 days), do not panic about losing metabolic health or mitochondrial density. While muscle mass may decrease, the cellular machinery for energy production remains largely intact during this specific timeframe, suggesting that immediate post-discharge recovery of metabolic function is feasible without needing to rebuild mitochondrial content from scratch.

Nutrient-based front-of-pack labeling systems (like Health Star Rating) can assign high health scores to ultra-processed foods, creating a 'health halo' that misleads consumers about the nutritional quality of convenience foods, sports/diet foods, and meat alternatives.

When evaluating packaged foods, do not rely solely on front-of-pack labels like the Health Star Rating. These systems focus on nutrients (sugar, sodium, fiber) but ignore how processed the food is. Look for the ingredient list: if it contains industrial additives, emulsifiers, or protein isolates, it is likely ultra-processed, even if it has a high health score. Prioritize whole, minimally processed foods over highly processed ones with 'good' nutrient profiles.

Handgrip strength reference values for European adults aged 50+ vary significantly by age, sex, and geographic region, with Northern and Western Europe showing higher absolute strength than Southern and Central/Eastern Europe, and standing position yielding higher values than sitting.

If you are over 50, do not compare your handgrip strength to a generic global average. Use the specific reference values for your age group, sex, and European region (Northern, Western, Southern, or Central/Eastern) to accurately assess your muscle health. Standing grip is typically higher than sitting; ensure you are comparing like with like.

Current precision nutrition products and nutrigenomics concepts promoted on social media frequently contain misleading or untrue information, particularly regarding the readiness of personalized diets and the ability of specific foods to alter DNA.

Be skeptical of social media posts claiming that specific diets or supplements can change your DNA or that personalized nutrition products are ready for general use. The scientific consensus is that these technologies are not yet ready for broad application, and many products contain misleading or untrue information. Focus on evidence-based dietary patterns rather than unproven genetic tailoring products.

In Chronic Kidney Disease, Heart Failure, Liver Disease, Psoriasis, Rheumatoid Arthritis, and COPD, elevated CRP is NOT explained by adiposity alone, indicating independent inflammatory pathology driven by end-organ damage or tissue-specific inflammation.

If you have CKD, Heart Failure, Liver Disease, Psoriasis, RA, or COPD, your high CRP is likely due to the disease process itself, not just your weight. While weight management is still beneficial, you likely need specific treatments targeting the organ damage or autoimmune response, as weight loss alone may not resolve the inflammation.

In individuals with ideal cardiovascular health (high CVHS), elevated BMI (≥35.0 kg/m²) does not significantly increase the risk of incident atherosclerotic cardiovascular disease (ASCVD) compared to normal BMI, whereas low cardiovascular health strongly predicts ASCVD regardless of BMI.

If you have ideal cardiovascular health (normal blood pressure, lipids, glucose, no smoking, active, healthy diet, good sleep), your risk of heart disease is low even if your BMI is high (≥35). Focus on maintaining these healthy habits rather than trying to lose weight. If your cardiovascular health score is low, your risk is high regardless of your BMI, so prioritize improving lifestyle and metabolic markers.

Markov models are the dominant methodological framework for economic evaluations of obesity interventions, with 85% of reviewed studies utilizing state-transition models.

When evaluating the long-term cost-effectiveness of obesity treatments, decision-makers should expect and look for Markov modeling. This is the standard approach for comparing interventions like bariatric surgery, pharmacotherapy, and lifestyle changes over a patient's lifetime.

Current Markov models for obesity interventions exhibit significant methodological heterogeneity, particularly in how they model the progression of obesity and its impact on costs and utilities.

When comparing economic evaluations of obesity treatments, be aware that different studies use different structures (direct BMI-to-cost vs. BMI-to-complications). This makes direct comparison difficult. Look for studies that use standardized validation and include a broad spectrum of complications.

Diabetes mellitus (DM) and cardiovascular disease (CVD) are the most frequently modeled obesity-related complications in Markov models, with DM appearing in 15/15 models focusing on complications and CVD in 14/15.

If you are looking at an economic evaluation of an obesity treatment, expect it to focus heavily on preventing diabetes and cardiovascular events. These are the main drivers of long-term cost savings and quality-of-life improvements in these models.

Validation practices in Markov models for obesity interventions are inconsistently reported, with only 43% of models reporting validation, limiting the reliability and comparability of these evaluations.

Be cautious when using economic evaluations of obesity treatments that do not report validation. Only 43% of the models reviewed reported validation, which limits their reliability. Look for studies that use standardized validation guidelines like ISPOR.

Higher baseline BMI (30–40 kg/m²) correlates with lower health-related quality of life (utility indices), but the effect size is small (up to 0.005 per unit BMI) and often not statistically significant, suggesting BMI alone does not explain HRQoL differences.

While higher BMI is associated with slightly lower health utility scores, the impact is small and often not statistically significant. Do not assume your quality of life is defined by your BMI alone. Focus on managing specific comorbidities, age-related changes, and mental health, as these appear to be stronger drivers of your daily well-being than BMI itself.

Leucine-rich high protein supplementation (50.6 g protein and 6 g leucine daily) does not significantly improve body composition or muscle function in older adults with sarcopenia over a 12-week period, despite upregulating specific gene expression related to ATP production and DNA repair.

For older adults with sarcopenia, taking leucine-rich protein supplements alone for 12 weeks will not significantly increase muscle mass or improve physical function. While it may positively influence gene expression related to energy production, it is not a standalone solution for reversing sarcopenia. To see functional benefits, supplementation should likely be combined with resistance exercise.

Higher neighborhood-level socioeconomic disadvantage is associated with weaker statistical interactions (correlations) among the stages of adiposity, dysglycemia, and hypertension, suggesting that in disadvantaged populations, these cardiometabolic drivers develop more independently of one another.

If you live in a high-disadvantage neighborhood, standard assumptions about how weight affects blood sugar and blood pressure may not apply to you. The link between carrying extra weight and developing high blood sugar or high blood pressure is weaker in these settings. This suggests that factors like chronic stress, limited access to healthy food, and environmental stressors play a larger, independent role in your cardiometabolic health. Screening and prevention strategies should account for these social determinants rather than focusing solely on weight management.

Prolonged oral processing (chewing) increases in vitro protein and lipid digestion efficiency by mechanically breaking down the food matrix, but this does not necessarily translate to altered in vivo glycaemic responses in healthy individuals.

For healthy individuals, chewing your food more thoroughly will help your stomach enzymes break down proteins and fats more efficiently in the lab setting, but it won't significantly change your blood sugar levels or metabolic health. If you have pre-diabetes, thorough chewing may help regulate blood sugar, but for the general healthy population, the food's physical structure (e.g., whole nuts vs. ground) matters more for nutrient absorption than chewing time alone.

Substituting plant-based meats for animal meats for 8 weeks does not significantly improve biomarkers of inflammation in generally healthy adults.

Swapping animal meat for plant-based meat alternatives for 8 weeks is unlikely to reduce your inflammation markers if your overall diet remains unchanged. These products are often ultra-processed, which may negate potential benefits. Focus on whole, unprocessed plant foods rather than just substituting meat analogues.

Moderate to severe weight change (loss or gain) of ≥5% within a 2-year interval is associated with a significantly increased risk of suicide mortality, exhibiting a reverse J-shaped curve.

If you experience rapid, unintentional weight loss or gain (≥5% in 2 years), it is a significant physiological stress signal. While weight loss is often pursued for health, rapid changes—especially if unexplained by diet/exercise—warrant medical and psychological evaluation to rule out underlying conditions or mental health risks, rather than simply viewing the change as a success or failure.

The Obesity Lifecycle Model demonstrates favorable concordance with observed clinical and quality-of-life outcomes, validating its use for evaluating obesity-related complications and informing healthcare decision making.

Healthcare decision-makers can use the Obesity Lifecycle Model to assess the cost-effectiveness of obesity therapies with confidence, as it has been validated to accurately predict clinical complications and quality-of-life impacts.

Both bariatric surgery (RYGB/SG) and structured medical treatment (VLED) result in similar safety profiles regarding hospitalization, need for further surgery, and mortality at 2-year follow-up, despite differences in weight loss magnitude.

Safety outcomes, including hospitalization and mortality, are comparable between bariatric surgery and structured medical treatment at 2 years. This suggests that for many patients, the higher efficacy of surgery does not come with a proportionally higher immediate safety risk compared to medical management.

Ultraprocessed food (UPF) consumption does not have a unique mechanistic link to increased body mass index or obesity risk, as epidemiological associations are weak and mechanistic evidence is lacking or contradictory.

Do not avoid all processed foods based on the NOVA classification. Focus on nutrient density, portion control, and overall dietary patterns. Many processed foods are safe, nutritious, and affordable. Avoiding them entirely may lead to nutrient deficiencies and higher costs without proven health benefits.

Obesity is a neurobehavioral disorder resulting from the interaction of a 'vulnerable brain' (biological dysregulation of homeostatic and hedonic pathways) and an obesogenic food environment, rather than solely a failure of willpower.

If you struggle with obesity, understand that it is not just a lack of willpower. Your brain's biological signaling for hunger and satiety, combined with the modern food environment, creates a 'vulnerable brain' state. Effective management requires addressing both the biological signals (e.g., through medical or behavioral interventions) and the environment (e.g., reducing access to hyper-palatable foods).

Mitochondrial dynamics, specifically regulated by Drp1-mediated fission, are essential for maintaining muscle stem cell (satellite cell) regenerative competence and metabolic health throughout adult life.

As you age, your muscle stem cells rely on healthy mitochondrial function to repair tissue. While you cannot directly 'dose' Drp1, you can support mitochondrial health through regular physical activity and adequate nutrition, which are known to promote mitochondrial biogenesis and dynamics. This biological maintenance is key to preserving muscle mass and regenerative ability in adulthood.

Transforming urban provisioning systems through integrated spatial planning and supply-side innovations (e.g., active mobility, green infrastructure, clean energy) reduces cardiometabolic risk factors and improves cardiovascular health outcomes.

Advocate for and utilize urban designs that prioritize walking, cycling, and access to green spaces. If you live in a city, look for 'walkable' neighborhoods with mixed land use. If infrastructure is lacking, support policy changes for better transit and pedestrian safety, as these systemic changes directly lower your risk of cardiovascular disease and help maintain a healthy weight.

Co-administration of the GLP-1 receptor agonist liraglutide and nicotine synergistically lowers body weight in obese mice by simultaneously reducing food intake and increasing energy expenditure.

In obese mice, combining a GLP-1 drug (liraglutide) with nicotine resulted in greater weight loss than either drug alone. This happened because the combination reduced hunger more effectively and increased the body's energy expenditure. This suggests that for humans, smokers might experience enhanced weight loss from GLP-1 medications, or that specific nicotine-targeting strategies could boost GLP-1 efficacy.

Long-term weight loss maintenance is not significantly predicted by dietary adherence or caloric restriction, but is associated with baseline proteomic and gut microbiome signatures.

If you struggle to maintain weight loss despite good adherence, your baseline biology (proteins and gut bacteria) may be a factor. This suggests that personalized dietary strategies based on biological markers might be more effective than generic advice for long-term maintenance.